Cardiac profile of the Czech population of Duchenne muscular dystrophy patients: a cardiovascular magnetic resonance study with T1 mapping

Table 4 Comparison of segmental and global ECV

Segment	Group C (Controls) n = 13	Group D1 (LGE–) n = 23	Group D2 (LGE+) n = 20	p (C vs. D1)		p (C vs. D2)		p (D1 vs. D2)
Segment	Group C (Controls) n = 13	Group D1 (LGE–) n = 23	Group D2 (LGE+) n = 20	crude	age-adjusted	crude	age-adjusted	crude	age-adjusted
Anterior	0.243 ± 0.017	0.258 ± 0.030	0.266 ± 0.046	0.50	0.50	0.21	0.22	0.76	0.76
Anteroseptal	0.252 ± 0.015	0.258 ± 0.029	0.265 ± 0.057	0.93	0.93	0.69	0.69	0.83	0.83
Inferoseptal	0.251 ± 0.014	0.251 ± 0.030	0.264 ± 0.052	1.00	1.00	0.63	0.62	0.52	0.51
Inferior*	0.237 ± 0.015	0.252 ± 0.029	0.271 ± 0.045	0.50	0.51	0.033	0.035	0.18	0.18
Inferolateral*	0.236 ± 0.015	0.250 ± 0.031	0.338 ± 0.076	0.75	0.76	1.10 ⁻⁴	1.10 ^− 4	1.10 ^− 4	1.10 ^− 4
Anterolateral*	0.236 ± 0.016	0.251 ± 0.031	0.296 ± 0.066	0.65	0.65	0.003	0.003	0.008	0.008
Global*	0.243 ± 0.013	0.253 ± 0.028	0.280 ± 0.044	0.71	0.71	0.015	0.015	0.031	0.031

Variables are expressed as the mean ± standard deviation. Variables marked in bold and denoted with * have their ANOVA p-value < 0.05
P-values of the post hoc tests < 0.05 are marked in bold
ECV extracellular volume, LGE– negative late gadolinium enhancement, LGE+ positive late gadolinium enhancement

ISSN: 1750-1172